Sanofi Pasteur SA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Sanofi Pasteur SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014193
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sanofi Pasteur SA (Sanofi Pasteur), formerly Aventis Pasteur SA, a subsidiary of Sanofi, is a manufacturer and marketer of vaccines against bacterial and viral diseases. The company provides meningococcal vaccines and seasonal influenza vaccines. Its products are used in the treatment of cholera, diphtheria, haemophilus influenzae type b infections, meningococcal infections, pertussis, pneumococcal infections, tetanus, tuberculosis, typhoid fever, hepatitis A, hepatitis B, influenza, measles, mumps, poliomyelitis and rabies. The company operates in Algeria, Argentina, Australia, Austria, Belgium, Bangladesh, Brazil, Bulgaria, Canada, Chile, China, Malaysia, Pakistan, the Philippines, Russia, South Korea, Mexico and Indonesia, among others. Sanofi Pasteur is headquartered in Lyon, France.

Sanofi Pasteur SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Sanofi Pasteur SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Sanofi Pasteur SA, Medical Devices Deals, 2011 to YTD 2017 10
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Sanofi Enters into Co-Development Agreement with MedImmune 12
Sanofi Pasteur Expands R&D Agreement with Walter Reed Army Institute of Research and Bio Manguinhos and Fiocruz 13
Sanofi Pasteur Enters into Partnership with Infectious Disease Research Institute 14
Immune Design Enters into Co-Development Agreement with Sanofi Pasteur 15
Sanofi Pasteur Enters Into Agreement With SK Chemicals For Pneumococcal Conjugate Vaccine 16
Sanofi Pasteur Enters into Agreement with University of Melbourne to Develop Human Vaccines 17
Sanofi Pasteur Enters Into Agreement With Bill & Melinda Gates Foundation To Discover Vaccines 18
Sanofi Pasteur Enters Into Co-Development Agreement With Xiamen University For Universal Flu Vaccine 19
Sutro Biopharma Enters Into Co-Development Agreement With Sanofi Pasteur 20
CureVac Enters Into Co-Development Agreement With Sanofi Pasteur 21
Alliance Pharma Extends Distribution Agreement With Sanofi Pasteur For ImmuCyst 22
Sanofi Pasteur Enters Into An Agreement With International Vaccine Institute 23
Licensing Agreements 24
Sanofi Pasteur Expands Licensing Agreement With Vivalis 24
CureVac Enters into Licensing Agreement with Sanofi Pasteur to Develop mRNA-Based Prophylactic Vaccine 25
Sanofi Pasteur Enters Into Licensing Agreement With ORGANOBALANCE For Saccharomyces Cerevisiae 26
Sanofi Pasteur Enters Into Licensing Agreement With University of California, San Diego 27
Acquisition 28
Sanofi Pasteur Acquires Topaz Pharma For Up To US$207.5 Million 28
Sanofi Pasteur SA – Key Competitors 30
Sanofi Pasteur SA – Key Employees 31
Sanofi Pasteur SA – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Joint Venture 33
Recent Developments 35
Corporate Communications 35
Jun 27, 2017: American Academy of Family Physicians Foundation Launches Highlight on VACCINATIONS 4 TEENS to Help Address Teen Under-Vaccination 35
Product News 36
09/26/2016: BARDA Grants $43.2 million USD to Sanofi Pasteur for Zika 36
06/23/2016: New Four-Strain Influenza Vaccine, VaxigripTetra, regulatory dossier from Sanofi Pasteur now approved in Europe 37
02/02/2016: Sanofi Pasteur To Leverage Its Strong Vaccine Legacy In Hunt For Zika Vaccine 38
Clinical Trials 39
Aug 03, 2016: Vaccine Candidates Protect Against Zika Virus in Rhesus Monkeys 39
Mar 29, 2016: Sanofi Pasteur uses novel technology for development of a 2nd-gen influenza vaccine 40
Other Significant Developments 41
Sep 22, 2016: Sanofi Pasteur invests 300 million pesos to triple production capacity at its plant in Argentina 41
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Key Facts 2
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Sanofi Pasteur SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Sanofi Pasteur SA, Deals By Therapy Area, 2011 to YTD 2017 9
Sanofi Pasteur SA, Medical Devices Deals, 2011 to YTD 2017 10
Sanofi Pasteur SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Sanofi Enters into Co-Development Agreement with MedImmune 12
Sanofi Pasteur Expands R&D Agreement with Walter Reed Army Institute of Research and Bio Manguinhos and Fiocruz 13
Sanofi Pasteur Enters into Partnership with Infectious Disease Research Institute 14
Immune Design Enters into Co-Development Agreement with Sanofi Pasteur 15
Sanofi Pasteur Enters Into Agreement With SK Chemicals For Pneumococcal Conjugate Vaccine 16
Sanofi Pasteur Enters into Agreement with University of Melbourne to Develop Human Vaccines 17
Sanofi Pasteur Enters Into Agreement With Bill & Melinda Gates Foundation To Discover Vaccines 18
Sanofi Pasteur Enters Into Co-Development Agreement With Xiamen University For Universal Flu Vaccine 19
Sutro Biopharma Enters Into Co-Development Agreement With Sanofi Pasteur 20
CureVac Enters Into Co-Development Agreement With Sanofi Pasteur 21
Alliance Pharma Extends Distribution Agreement With Sanofi Pasteur For ImmuCyst 22
Sanofi Pasteur Enters Into An Agreement With International Vaccine Institute 23
Sanofi Pasteur Expands Licensing Agreement With Vivalis 24
CureVac Enters into Licensing Agreement with Sanofi Pasteur to Develop mRNA-Based Prophylactic Vaccine 25
Sanofi Pasteur Enters Into Licensing Agreement With ORGANOBALANCE For Saccharomyces Cerevisiae 26
Sanofi Pasteur Enters Into Licensing Agreement With University of California, San Diego 27
Sanofi Pasteur Acquires Topaz Pharma For Up To US$207.5 Million 28
Sanofi Pasteur SA, Key Competitors 30
Sanofi Pasteur SA, Key Employees 31
Sanofi Pasteur SA, Other Locations 32
Sanofi Pasteur SA, Subsidiaries 32
Sanofi Pasteur SA, Joint Venture 33

★海外企業調査レポート[Sanofi Pasteur SA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • North Central Electric Cooperative, Inc.:企業の戦略的SWOT分析
    North Central Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Athene Annuity & Life Assurance Company of New York:企業の戦略・SWOT・財務情報
    Athene Annuity & Life Assurance Company of New York - Strategy, SWOT and Corporate Finance Report Summary Athene Annuity & Life Assurance Company of New York - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's stru …
  • Murata Manufacturing Co Ltd (6981):企業の財務・戦略的SWOT分析
    Murata Manufacturing Co Ltd (6981) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Kalgene Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Kalgene Pharmaceuticals Inc (Kalgene Pharmaceuticals) is a pre-clinical stage biotechnology company focused on the development of novel fusion protein therapeutic's for the treatment of neurodegenerative diseases. Its lead product candidate KAL-ABP, targets toxic amyloid beta oligomers that …
  • Integrated BioTherapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Integrated BioTherapeutics Inc (IBT) is a biotechnology company that discovers novel vaccines and therapeutics for infectious diseases. The company's products include polyclonal and monoclonal antibodies raised against various emerging pathogens, vaccines and therapeutics against bacteria, p …
  • Sterigenics International LLC:医療機器:M&Aディール及び事業提携情報
    Summary Sterigenics International LLC (SteriGenics), formerly Radiation Sterilizers Inc, a subsidiary of Gtcr Llc, is a medical device company that offers sterilization technologies such as gamma irradiation, electron beam and ethylene oxide. The company was formerly known as Radiation Sterilizers, …
  • Oramed Pharmaceuticals Inc (ORMP):企業の財務・戦略的SWOT分析
    Oramed Pharmaceuticals Inc (ORMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Wns (Holdings) Limited
    Wns (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary Wns (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Solstad Farstad ASA (SOFF):石油・ガス:M&Aディール及び事業提携情報
    Summary Solstad Farstad ASA (Solstad), formerly Solstad Offshore ASA is an oil and gas company that provides vessel operation solutions. The company offers carbon footprint, climate neutral network, offshore shipping, green operations, and rainforest protection, documentation programs, and others. I …
  • Botswana Power Corporation:企業の戦略的SWOT分析
    Botswana Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Diebold Nixdorf, Incorporated:企業の戦略・SWOT・財務分析
    Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Diebold Nixdorf, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • DSG Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary DSG Inc (DSG) is a provider of eClinical software solutions. The company offers software products such as eCaseLink EDC, eClinDirect CTMS, eCaseLink.Me ePRO, DSG Drug Safety, eCaseLink IRT, DSG Designer, CaseXport, CaseView Imaging, and others. Its services include data management, technolog …
  • Eldorado Gold Corporation:企業の戦略・SWOT・財務情報
    Eldorado Gold Corporation - Strategy, SWOT and Corporate Finance Report Summary Eldorado Gold Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Alexion Pharmaceuticals, Inc.
    Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • PT Pertamina (Persero):企業の戦略・SWOT・財務分析
    PT Pertamina (Persero) - Strategy, SWOT and Corporate Finance Report Summary PT Pertamina (Persero) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • IndusInd Bank Ltd:戦略・SWOT・企業財務分析
    IndusInd Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary IndusInd Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Great Western Bancorp Inc:企業の戦略・SWOT・財務分析
    Great Western Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary Great Western Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • WorleyParsons Limited:企業の戦略・SWOT・財務情報
    WorleyParsons Limited - Strategy, SWOT and Corporate Finance Report Summary WorleyParsons Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Engro Corp Ltd (ENGRO)
    Engro Corp Ltd (ENGRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • NGEx Resources Inc:企業の戦略・SWOT・財務情報
    NGEx Resources Inc - Strategy, SWOT and Corporate Finance Report Summary NGEx Resources Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆